San Francisco, United States
Invitae, now part of LabCorp, is a prominent player in the Biotechnology and Health Care industries, founded in 2010. The company is headquartered in the United States and operates with a mission to integrate comprehensive genetic information into mainstream medicine, thus enhancing healthcare outcomes. Trusted by millions, Invitae provides precise genetic insights through innovative digital technology, which strongly influences medical decision-making and patient care.
The recent acquisition by LabCorp, valued at $239.00 million as of 01 August 2024, underscores a strategic move to further leverage Invitae's robust genetic expertise and technological edge. Known for employing machine learning, artificial intelligence, and robotics, the company stands at the forefront of genetic research and application, impacting individual and familial health decisions.
Invitae fosters a dynamic internal culture that prioritizes team collaboration and innovation, offering employees the flexibility needed for growth. As they continue to center patient genetic insights within healthcare, Invitae emerges as a pivotal entity influencing future directions in genetic solutions.
CancerIQ